CDK4 and hepatocellular carcinoma: In TIMER2.0 results as shown in Additional files 4, 5, 6: Figure S4-6, CDK1 and CDK4 showed high expression in HCC and other cancers and were positively correlated with TP53 gene mutation, a common mutation site in HCC.